Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I've often seen a big dip to trip stop losses and acquire shares juuust before a big pop.
I think it'll be awesome to close today at or below open, get typical update info at 6p (nothingburger in the grand scheme), and then gap up Monday... except we've already traded up to .27 pps this week so it won't be a gap needing to fill.
- Go $RDGL!!
For the big picture, read thru their filings, PR's, and/or X tweets/updates...
As a start, visit their webpage:
By June 2024
-Go $RDGL!!!
Using their $7.4 Billy number from 2023, if they only get 10% of that Market Capitalization, then we are looking at roughly $1.90 pps with the current share structure... interesting.
They identify other targeted uses as well:
Nice! AND if you turned in your beer cans today you could buy a share in the company for every 2 cans returned!
I might finally need to clean out the bins n bags in my garage... my 2002 SUV could use a headlight upgrade to these new fangled LED headlights!
Hay, anyone think we might see .30 pps in a month or two? Pappy needs to reattach some running boards :-p
-Go $RDGL!!!
And yet yesterday's trading pattern looked to me like maybe 100 share/200 share low ball trades trying to trigger "stop loss" share sells for someone to pick up cheap volume.
Some of us have seen what THAT looks like before, short term... lol
Ahh, crap! Now that I said that out loud Imma gonna hafta recycle more cans tomorrow n pick up a couple more shares...
Next time someone chats with Dr. Mike, maybe they could bring up patient immune response testing and share a reply here?
Pre-mRNA vaccine, virus cells with inactivated DNA were grown and used as the vaccine for flu, measles, etc... Given that the patient absorbs the tumor post treatment with Isopet/Radiogel, is there a way to test immune response in the patient to the absorbed tumor cells? Can a successful Radiogel/Isopet treatment be demonstrated to create a patient specific immune response similar to vaccination for future occurrences of similar cancer cells/ tumors?
Just spit-balling potential pieces of the iceburg here...
-Go $RDGL
Hm, the CEO is an MIT guy who got his device designated as a "Break through Device" by the FDA in a biomed market where such devices already have a 20 year history of being FDA approved... AND his device is already FDA approved and used in the Veterinarian community by doctors?
With a share price of 10 cents, maybe I'll finish this beer n then go return some weekend bottles n cans so I can buy more shares over the lunch time sell off!
1 empty recycled can per share? Volume could show up any day now...ROFL
-Go $RDGL
Whoops, I like to link to info I refer to whenever I can. We have had multiple rabbit studies done, written up and submitted to National Institute of Health, etc... despite what some fudsters may have claimed. I link an old May 2021 write up as a reference for anyone new here:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996238/
-Go $RDGL
Pre-submission share prices will likely be market driven. Timing matters.
Dr. Mike has always been clear in his communication regarding FDA and why. He says stuff will be ready to support our IDE this quarter, then that is for real...
Is it possible FDA won't receive it for review till July? I guess we'll find out, lol. Mebbe it gets submitted by Mother's Day?
Given our recent BDD status award and level of ongoing communication combined with our genotoxicity and rabbit tumor results, mebbe FDA won't need 30 days to give a go ahead for our human safety trial?
I think timing drives events that drive share price as we see results.
Bottom line: Does the deep state US or this Administration want good news on cancer therapy pre November? Post November?
I think it promises to be a fun show to watch!
-Go $RDGL
Macro Overview: Cancer costs by 2030 estimated to be in the $580 Billion market cap range.
Source:
https://www.globenewswire.com/news-release/2022/01/21/2370991/0/en/Oncology-Market-Size-to-Hit-US-581-25-Billion-by-2030.html
Brachytherapy is forecasted by some to reach $1.62 Billion in revenue by 2030. at a 10X multiple (I think Biomed has higher profit margins but 10% is conservative) that looks like $16.2 Billion usd (less than 3% of cancer market) in cancer Market share
Source:
https://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market
Cancer cases globally are expected to grow 77% by 2050.
Source:
https://www.iarc.who.int/wp-content/uploads/2024/02/pr345_E.pdf
I figger RDGL might get 10% of the brachytherapy market cap with their 18 revenue verticals identified by their distinguished MAB (Medical Advisory Board).
My guess is that they dilute their shares (111 million additional OS) in an offering once their pps is comfortably over $1 usd to raise mebbe $100 million usd to fund their growth.
At 500 milly OS, with $100milly in hand looking at a possible $1.62 Billy Market share and a 77% 20 year growth rate a price per share around $3.24 seems reasonable to me. That COMPLETELY ignores the veterinarian side as well as an expansion possibly into joint pain treatment, etc,,,
If a company wants to buy us out to preserve their own market share and possibly grow it, I imagine a $5-$10 per share buyout range might be reasonable.
Our brachytherapy has higher quality gel, NO resin/glass/metal beads, and uses a beta emitter with about a quarter inch emission range that is completely depleted in under 3 days anyway... mebbe targeting 10% of the 3% cancer market assigned for brachytherapy is too low ball?
-Go $RDGL
LOL, 2 milly share volume 10k on the ask and 5k on the bid?
I have seen this movie before... and they hate it when someone keeps buying on their ask!
-Go $RDGL
I'm buying more at these levels in place of my usual crypto weekend play...
I was waiting for whomever bought those 500k share blocks from retail in the low .05s 4 months ago to sell off n get their core out.
reset the RSI some n next week or end of month could get interesting!
-Go $RDGL
Nothing says "unicorn" like being able to claim your breakthrough device idea/product is used in creatures you can safely pet both pre and post treatment!
#35 on the breakout board looks like an event might be happening this quarter?
It looks to me like the future MOMO traders are in early entry stages?
Post submit to FDA for human safety trials, I expect volatility as the momo folks either build share count, trade to get paid, or both. Who can blame them for buying up the under .15 pps crowd when we were pushing .30 on the last submit to FDA?
Personally, I set all my shares to sell above $65pps as a GTC (good until cancelled) play. Has anyone else ever enjoyed a "locked float" price run?
This time, I think we have a MUCH higher likelihood for success/approval given our recent BDD achievement so mebbe .30pps is pretty low-balled? Time will tell...
-Go $RDGL
The way we must look to some folks, lol...
The way we must look to some folks, lol...
Lol, Congratz!
Me i'm just waiting for the better quality FOMO folks to show up. The main detracter here is posting like one of my grade school grandkids (LMFAO)
That'll indicate this board is valuable to spend time on.
Sell me your shares at .05 pps or buy them back from me in the $5-$10 pps range... the current posts are still not gonna change my crypto profits!
-Go $RDGL
If you are just now following this board, here is a message from one of our more prolific Bear posters (Dated 2/16/24 and linked unless he deletes it)
While imo RDGL is fairly priced now given last offering and the risk, it's hard to see this holding a nickle.
If you are looking for an entry point to invest, the 52 week low is .04119 pps and the high was .1195 pps.
I am a buy low sell high kinda guy myself, but to each his own.
When the average poster of pedestrian critique agrees this is a fair price, sometimes I agree with them?
LOL, you know the type: The FDA doesn't talk with the ceo cuz if they did they'd need to record it under an ID that doesn't exist... blah-blah
Whoops, and just like that I got bored again...
I'll check back in another couple weeks
-Go $RDGL
When my post includes Blue Text, its cuz I linked my source to a web page.
Investopedia definitions, American Bar Association, the American NIH or Cancer info clearing houses... Maybe a bear or two here don't know how to do that?
Bear Case:
Isopet is all these folks have and it has no value or future.
Radiogel has no FDA record number or submissions to FDA under any ID number... much less an active developing IDE application
My Reply:
A Half Dozen part time clinics represent a roughly $20 Million Market Cap today at .05pps
So the Bears are really saying:
If we add double our clinic count each quarter for the next 2 Quarters that would be 6+12+24= 42 clinics by year end?
So maybe the Bear case is 7 times .05 pps yields .35 pps by a future Christmas?
CHANGE MY MIND, lol, and please link your sources so I can understand you. When Trademarks/ Copyrights are literally defined as IP, but you state "the market" and you agree they are NOT IP then I'd like to read your sources for myself.
Can we have a real dialog here?
-Go $RDGL
I'm excited to be buying shares in this range. Sounds like I can thank Isopet for that.
My question is: What word will I call it when the next FDA meeting gets set?
If Radiogel gets Human safety trial approval, AND Isopet proves helpful with joint pain relief in lame horses... could that be a segue into a joint pain relief use for our "super cheap to produce" gel? Isn't that an opening to a possible $5 Billion Market?
-Go $RDGL
I'm always "interested" when a ceo takes an OTC company from "toxic death spiral financing" using a product like Isopet as proof of concept in protection of their IP and then they open clinics... did they double their clinic count this quarter yet for Isopet?
From reverse split to OTC QB gold standard selling only Isopet? The QB is literally gold colored on my screen at OTC RDGL research web site
-Go $RDGL
Most Interesting Man:
I don't ALWAYS have pets with cancer....
Don't take MY word on Isopet's value
Most Interesting Man on Isopet
-Go $RDGL
LOL, Exciting will be the day I can upgrade my 2002 Ford Exploder with my gains from an OTC stock... Mebbe LED headlights?
This ticker has potential to get me to switch to Scotch from Rum!
I'm thinking that sometime tween now n Spring we hear about a report package transmittal to FDA requesting a presubmittal / final review.
Volatility leading up to that next FDA meeting could be choice!
Meanwhile Isopet growth only makes sense to me.
Do you, or anyone, know the annual dollars spent on joint pain / injury in the US?
-Go $RDGL
Bears n Bulls share your DD?
Lets have a chat. Share your thoughts with links?
-Go $RDGL
Isopet promotion sounds like good IP Strategery to me, lol...
https://www.americanbar.org/groups/intellectual_property_law/publications/landslide/2015-16/september-october/what-s-it-worth-principles-patent-valuation/
Put on our Wizards of Smart hats:
Everyone else:
Cost to produce radio-isotope +
Cost to produce medical grade "seed" +
Cost to impregnate seeds with radio-isotope at a regulated, predictable dose to patient concentration +
Cost to create gel / fluid used for suspension of a radio-isotope +
Cost to uniformly mix radio-isotope impregnated seeds into suspension
= product cost structure rough approximation for all current, approved Brachytherapy using seeds
& 25% possible seed migration complication risk
Radiogel:
Cost to produce radio-isotope +
Cost to create gel / fluid used for suspension of a radio-isotope +
Cost to uniformly mix radio-isotope into suspension
= Isopet / Radiogel rough cost approximation
& 0 seed migration risk as no seeds are used,
Can anyone out there put numbers to estimate the potential cost savings for a bidder should they purchase our IP protected Brachytherapy production method?
-Go $RDGL
We don't have a "seed migration issue" if we don't use "seeds" in our Radiogel or Isopet products, imho.
Here is another from Investopedia about Intellectual Property:
Trademark and Copyrights are IP
Anyone else feel excited as they share their DD around?
This seems a good time to change the mood a little. Maybe we can do some value added and start chats about what we see here?
https://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market
-Go $RDGL
These Nickel bags are sooo YUMMY!
-Go $RDGL
Same here all last month. I like to see it with this share structure.
Imho, MM's have to make a market by definition. Sometimes they do that by selling shares they don't have yet, then driving the share price down with tiny volume sells (100 shares) and 5-10k share fills at or below bid.
If they can then satisfy their higher sells thru lower pps buys, then they have profited and made a market.
Their struggle is the new year/quarter with news pending. Lower pps shares get bought n not flipped. If their share deficit exists when news comes out they will gobble shares to clear their deficit n then profit off the flips on the quick rise in share price as the market makes itself.
)
- Go $RDGL
See how easy it is to get certain folks to follow our posts and respond to us?
We need FUD spreaders with better initiative, imho, if i have any hope of ever buying nickel shares again!
Lol, and just like that i got bored again. I'll check back in a week or 2 from now.
- go $RDGL
Lol, as apple mac fans used to say:
Don't be a Sc8da h8a playa, hate the game!
I'm in the camp that hopes our FUD folks get an upgrade so that they bring the price back down under my pps average into the nickel range.... but that's just me getting greedy.
Not everyone can do statistics n probability or spreadsheets. I get that.
From strong foundations come strong structures! Isopet is a very real, living example of what this could become. Wizards of smart may take notice this year.
I don't care if Gilead Sciences, for example, tell me the truth about all their intended uses for our Hydrogel... but a $16.00USD offer per share might get my attention so that i'd have to seriously pay attention to exactly what lies are being said. )
- Go $RDGL
Ahh, thank you for that info... that input into my spreadsheet doubles my guess at price per share for a licensing revenue path then...
- Go $RDGL
Thank you for the interest in my question!
Something else to consider:
While Vivos is being setup as the company to deliver this Market Cap in 5-10 years there do exist other ways for income to be generated that require less corporate expenditure. Battelle made money off us just in licensing...
Do we sell our Isopet treatment at cost? Is cost around $4k?
What PERCENTAGE of our treatment cost is the hydrogel product?
Example: hydrogel assumed at 25% of treatment cost. We license our IP at 30% of that cost for the privilege of using our product. If 10% of Cancer dollars are Brachytherapy of some kind, 25% of that is hydrogel and we get 30% of that number then where does that fall?
Just throwing numbers out, but does anyone have actual numbers? Maybe that could bracket a low end Market Cap?
- Go $RDGL
Has anyone here found current numbers for Domestic US, and/or global cancer dollars spent defining a market?
My research was 2020 numbers and Brachytherapys (already FDA approved as dangerous devices due to particle travel) represented 8-11% of the total dollars spent. This was due to Brachytherapy, even with the particle travel problem, still being the best solution for certain cancers.
If our Radiogel, without the particle travel problem, gets approval and only gets used 1 of 8 times.... in other words our Market is only 1% of the Domestic or global cancer dollars... what range is that number in?
Also, our IP also protects our hydrogel's use with all things OTHER than radioisotopes but that is a different discussion to have post FDA approval, lol.
- go $RDGL
The point addressed in Isopet has always been the 3 year travel studies i read thru.
Radiating anything and suspending it in hydrogel then using a brachytherapy device to inject a patient has proven that the radiated thing travels in the patient and can lodge in vital organs.
Glass beads can't be detected via xrays, but they can block capillary blood flow to, say, heart muscle, kidneys, etc...
That story doesn't improve with titanium pellets, tiny darts or any other currently FDA approved Bracytherapy solution.
Our IP makes our product the ONLY brachytherapy, globally, that suspends the radioisotope into the hydrogel itself successfully, nontoxically. A feat global multi-billion dollar corporate labs were unable to achieve despite trying for the decades Batelle held the patent. We've been demonstrating proof of concept for years now in Isopet. Imho, we trial in humans soon.
- Go $RDGL
I expected a floating price between 6.5 and 8 cents this week and next... imagine buying someone's 500k share sell at around .05 cents a week or 2 ago, then selling in the high 7's to max your cash return, then buying into the offering at either 6.5 or 8 or whatever it was to maximize your long return.
Lol, someone understands "value added"?
- go $RDGL
Looks to me like yesterday's half million share seller at .05 range now wants back in....
)
- go $RDGL